FDA Notices of Judgment Collection, 1908-1966

2516. Adulteration and misbranding of Millard's Triple Prescription Formula Tablets No. 1 and misbranding of Millard's Triple Prescription Formula Tablets No. 2 and No. 3. U. S. v. The Millard Co. and Millard H. Krasne. Pleas of guilty. Fines of $120 against the company and $80 against the individual, together with costs.